Fintel reports that on April 17, 2025, Loop Capital upgraded their outlook for Warby Parker (NYSE:WRBY) from Hold to Buy.

You know that burning or crawling sensation that makes you want to scratch dry skin? It's awful—especially when it's in a ...

Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused on launching ...

Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused on launching Pelthos' ZELSUVMI ZELSUVMI is an FDA-designated novel drug an ...

SEMDEXA™ (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a wholly-owned subsidiary of Scilex Holding Company. A proprietary name review by the FDA is planned. ZTlido ® is a registered ...

HALT spectacle lenses can significantly reduce myopic progression independently from, or as a supplement to, low-dose atropine.